Scientific Papers

Low expression of PINK1 and PARK2 predicts poor prognosis in patients with esophageal squamous cell carcinoma | World Journal of Surgical Oncology


  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

    Article 
    PubMed 

    Google Scholar
     

  • Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64(3):381–7.

    Article 
    PubMed 

    Google Scholar
     

  • Zhao Y, Zhao W, Li J, Lin S, Li L, Ren Z, Lu J, Xing X, Liu X. Effect of dietary consumption on the survival of esophageal squamous cell carcinoma: a prospective cohort study. Eur J Clin Nutr. 2022;77(1):55–64.

    Article 
    PubMed 

    Google Scholar
     

  • Chen Y, Ye J, Zhu Z, Zhao W, Zhou J, Wu C, Tang H, Fan M, Li L, Lin Q, et al. Comparing paclitaxel plus fluorouracil versus cisplatin plus fluorouracil in chemoradiotherapy for locally advanced esophageal squamous cell cancer: a randomized, multicenter, phase III clinical trial. J Clin Oncol. 2019;37(20):1695–703.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wu C, Wang Z, Song X, Feng XS, Abnet CC, He J, Hu N, Zuo XB, Tan W, Zhan Q, et al. Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations. Nat Genet. 2014;46(9):1001–6.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lesseur C, Ferreiro-Iglesias A, McKay JD, Bosse Y, Johansson M, Gaborieau V, Landi MT, Christiani DC, Caporaso NC, Bojesen SE, et al. Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers. PLoS Genet. 2021;17(3):e1009254.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chang J, Tan W, Ling Z, Xi R, Shao M, Chen M, Luo Y, Zhao Y, Liu Y, Huang X, et al. Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations. Nat Commun. 2017;8:15290.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lin Y, Chen Q, Liu QX, Zhou D, Lu X, Deng XF, Yang H, Zheng H, Qiu Y. High expression of DJ-1 promotes growth and invasion via the PTEN-AKT pathway and predicts a poor prognosis in colorectal cancer. Cancer Med. 2018;7(3):809–19.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Panicker N, Ge P, Dawson VL, Dawson TM. The cell biology of Parkinson’s disease. J Cell Biol. 2021;220(4):e202012095.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ejma M, Madetko N, Brzecka A, Guranski K, Alster P, Misiuk-Hojlo M, Somasundaram SG, Kirkland CE, Aliev G. The links between Parkinson’s disease and cancer. Biomedicines. 2020;8(10):416.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang M, Luan S, Fan X, Wang J, Huang J, Gao X, Han D. The emerging, multifaceted role of PINK1 in cancer biology. Cancer Sci. 2022;113(12):4037–47.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kia DA, Zhang D, Guelfi S, Manzoni C, Hubbard L, Reynolds RH, Botia J, Ryten M, Ferrari R, Lewis PA, et al. Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets. JAMA Neurol. 2021;78(4):464–72.

    Article 
    PubMed 

    Google Scholar
     

  • Hardy J. Genetic analysis of pathways to Parkinson disease. Neuron. 2010;68(2):201–6.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Matsuda S, Nakanishi A, Minami A, Wada Y, Kitagishi Y. Functions and characteristics of PINK1 and Parkin in cancer. Front Biosci (Landmark Ed). 2015;20(3):491–501.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Li C, Pan Y, Tan Y, Wang Y, Sun X. PINK1-dependent mitophagy reduced endothelial hyperpermeability and cell migration capacity under simulated microgravity. Front Cell Dev Biol. 2022;10:896014.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Beilina A, Van Der Brug M, Ahmad R, Kesavapany S, Miller DW, Petsko GA, Cookson MR. Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc Natl Acad Sci U S A. 2005;102(16):5703–8.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Berthier A, Navarro S, Jimenez-Sainz J, Rogla I, Ripoll F, Cervera J, Pulido R. PINK1 displays tissue-specific subcellular location and regulates apoptosis and cell growth in breast cancer cells. Hum Pathol. 2011;42(1):75–87.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Liu Y, Lear TB, Verma M, Wang KZ, Otero PA, McKelvey AC, Dunn SR, Steer E, Bateman NW, Wu C, et al. Chemical inhibition of FBXO7 reduces inflammation and confers neuroprotection by stabilizing the mitochondrial kinase PINK1. JCI Insight. 2020;5(11):e131834.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Satoh K, Yachida S, Sugimoto M, Oshima M, Nakagawa T, Akamoto S, Tabata S, Saitoh K, Kato K, Sato S, et al. Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC. Proc Natl Acad Sci U S A. 2017;114(37):E7697–706.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Li J, Xu X, Huang H, Li L, Chen J, Ding Y, Ping J. Pink1 promotes cell proliferation and affects glycolysis in breast cancer. Exp Biol Med (Maywood). 2022;247(12):985–95.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Yamashita K, Miyata H, Makino T, Masuike Y, Furukawa H, Tanaka K, Miyazaki Y, Takahashi T, Kurokawa Y, Yamasaki M, et al. High expression of the mitophagy-related protein Pink1 is associated with a poor response to chemotherapy and a poor prognosis for patients treated with neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Ann Surg Oncol. 2017;24(13):4025–32.

    Article 
    PubMed 

    Google Scholar
     

  • Wang XL, Feng ST, Wang ZZ, Yuan YH, Chen NH, Zhang Y. Parkin, an E3 ubiquitin ligase, plays an essential role in mitochondrial quality control in Parkinson’s disease. Cell Mol Neurobiol. 2021;41(7):1395–411.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Johnson BN, Berger AK, Cortese GP, Lavoie MJ. The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax. Proc Natl Acad Sci U S A. 2012;109(16):6283–8.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lee MH, Cho Y, Jung BC, Kim SH, Kang YW, Pan CH, Rhee KJ, Kim YS. Parkin induces G2/M cell cycle arrest in TNF-alpha-treated HeLa cells. Biochem Biophys Res Commun. 2015;464(1):63–9.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • De Snoo ML, Friesen EL, Zhang YT, Earnshaw R, Dorval G, Kapadia M, O’Hara DM, Agapova V, Chau H, Pellerito O, et al. Bcl-2-associated athanogene 5 (BAG5) regulates Parkin-dependent mitophagy and cell death. Cell Death Dis. 2019;10(12):907.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Fujiwara M, Marusawa H, Wang HQ, Iwai A, Ikeuchi K, Imai Y, Kataoka A, Nukina N, Takahashi R, Chiba T. Parkin as a tumor suppressor gene for hepatocellular carcinoma. Oncogene. 2008;27(46):6002–11.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I, Janakiraman M, Schultz N, Hanrahan AJ, Pao W, et al. Somatic mutations of the Parkinson’s disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet. 2010;42(1):77–82.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Duan H, Lei Z, Xu F, Pan T, Lu D, Ding P, Zhu C, Pan C, Zhang S. PARK2 suppresses proliferation and tumorigenicity in non-small cell lung cancer. FRONT ONCOL. 2019;9:790.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bhat ZI, Kumar B, Bansal S, Naseem A, Tiwari RR, Wahabi K, Sharma GD, Alam RM. Association of PARK2 promoter polymorphisms and methylation with colorectal cancer in North Indian population. Gene. 2019;682:25–32.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Liu J, Zhang C, Wu H, Sun XX, Li Y, Huang S, Yue X, Lu SE, Shen Z, Su X, et al. Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression. J Clin Invest. 2020;130(6):3253–69.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yan C, Gong L, Chen L, Xu M, Abou-Hamdan H, Tang M, Desaubry L, Song Z. PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis. Autophagy. 2020;16(3):419–34.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Liu K, Lee J, Kim JY, Wang L, Tian Y, Chan ST, Cho C, Machida K, Chen D, Ou JJ. Mitophagy controls the activities of tumor suppressor p53 to regulate hepatic cancer stem cells. Mol Cell. 2017;68(2):281–92.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Porporato PE, Filigheddu N, Pedro J, Kroemer G, Galluzzi L. Mitochondrial metabolism and cancer. Cell Res. 2018;28(3):265–80.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Xu Y, Lu J, Tang Y, Xie W, Zhang H, Wang B, Zhang S, Hou W, Zou C, Jiang P, et al. PINK1 deficiency in gastric cancer compromises mitophagy, promotes the Warburg effect, and facilitates M2 polarization of macrophages. Cancer Lett. 2022;529:19–36.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhu L, Wu W, Jiang S, Yu S, Yan Y, Wang K, He J, Ren Y, Wang B. Pan-cancer analysis of the mitophagy-related protein PINK1 as a biomarker for the immunological and prognostic role. Front Oncol. 2020;10:569887.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Agnihotri S, Golbourn B, Huang X, Remke M, Younger S, Cairns RA, Chalil A, Smith CA, Krumholtz SL, Mackenzie D, et al. PINK1 Is a negative regulator of growth and the Warburg effect in glioblastoma. Cancer Res. 2016;76(16):4708–19.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Che L, Wu JS, Du ZB, He YQ, Yang L, Lin JX, Lei Z, Chen XX, Guo DB, Li WG, et al. Targeting mitochondrial COX-2 enhances chemosensitivity via Drp1-dependent remodeling of mitochondrial dynamics in hepatocellular carcinoma. Cancers (Basel). 2022;14(3):821.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Chen J, Zhou C, Yi J, Sun J, Xie B, Zhang Z, Wang Q, Chen G, Jin S, Hou J, et al. Metformin and arsenic trioxide synergize to trigger Parkin/pink1-dependent mitophagic cell death in human cervical cancer HeLa cells. J Cancer. 2021;12(21):6310–9.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lu X, Liu QX, Zhang J, Zhou D, Yang GX, Li MY, Qiu Y, Chen Q, Zheng H, Dai JG. PINK1 overexpression promotes cell migration and proliferation via regulation of autophagy and predicts a poor prognosis in lung cancer cases. Cancer Manag Res. 2020;12:7703–14.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Truban D, Hou X, Caulfield TR, Fiesel FC, Springer W. PINK1, Parkin, and mitochondrial quality control: what can we learn about Parkinson’s disease pathobiology? J Parkinsons Dis. 2017;7(1):13–29.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gupta A, Anjomani-Virmouni S, Koundouros N, Dimitriadi M, Choo-Wing R, Valle A, Zheng Y, Chiu YH, Agnihotri S, Zadeh G, et al. PARK2 depletion connects energy and oxidative stress to PI3K/Akt activation via PTEN S-nitrosylation. Mol Cell. 2017;65(6):999–1013.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Li C, Zhang Y, Cheng X, Yuan H, Zhu S, Liu J, Wen Q, Xie Y, Liu J, Kroemer G, et al. PINK1 and PARK2 suppress pancreatic tumorigenesis through control of mitochondrial iron-mediated immunometabolism. Dev Cell. 2018;46(4):441–55.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Liu J, Zhang C, Zhao Y, Yue X, Wu H, Huang S, Chen J, Tomsky K, Xie H, Khella CA, et al. Parkin targets HIF-1alpha for ubiquitination and degradation to inhibit breast tumor progression. Nat Commun. 2017;8(1):1823.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Elliott IA, Dann AM, Xu S, Kim SS, Abt ER, Kim W, Poddar S, Moore A, Zhou L, Williams JL, et al. Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion. Proc Natl Acad Sci U S A. 2019;116(14):6842–7.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     



  • Source link